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A B S T R A C T
Gastric ulcers are a significant medical problem and the development of complications 
lead to significant mortality rates worldwide. In Brazil, Carthamus tinctorius L., Asteraceae, 
seeds essential oil, the safflower oil, is currently used as a thermogenic compound and as 
treatment for problems related to the cardiovascular system. In this study, by Raman spec-
troscopy, it was shown that oleic and linoleic acids are the compounds present in higher 
concentrations in the safflower oil. We demonstrated that safflower oil (750 mg/kg, p.o.) de-
crease the ulcerogenic lesions in mice after the administration of hydrochloric acid-ethanol. 
The gastric ulcers induced by non-steroidal anti-inflammatory drug (NSAID) in mice treated 
with cholinomimetics were treated with four different doses of safflower oil, of which, the 
dose of 187.5 mg/kg (p.o.) showed significant antiulcerogenic properties (**p < 0.01). More-
over, the safflower oil at doses of 187.5 mg/kg (i.d.) increased the pH levels, gastric volume 
(**p < 0.01) and gastric mucus production (***p < 0.001), and decreased the total gastric acid 
secretion (***p < 0.001). The acute toxicity tests showed that safflower oil (5.000 mg/kg, p.o.) 
had no effect on mortality or any other physiological parameter. Ecotoxicological tests per-
formed using Daphnia similis showed an EC50 at 223.17 mg/l, and therefore safflower oil can 
be considered “non-toxic” based on the directive 93/67/EEC on risk assessment for new noti-
fied substances by European legislation. These results indicate that the antiulcer activity of 
Safflower oil may be due to cytoprotective effects, which serve as support for new scientific 
studies related to this pathology.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction
The development of peptic ulcers is one of the world’s major 
gastro-intestinal disorders, including both gastric and duodenal 
ulcers, which affects 10% of the global population (Zapata-
Colindres et al., 2006). The pathophysiology of peptic disease is 
attributed to an imbalance between aggressive factors like acid, 
pepsin, and an Helicobacter infection, and local mucosal defenses 
like bicarbonate, mucus and prostaglandin secretion (Jain et al., 
2007). Helicobacter pylori infection, the use of non-steroidal anti-
inflammatory drugs (NSAID), emotional stress, alcohol abuse, 
and smoking are the principal etiological factors associated with 
peptic ulcer development (Malfertheiner et al., 2009).
There are several drug treatments used to treat gastric ulcer. 
These include gastric acid neutralizing therapeutic drugs (e.g. 
aluminum hydroxide and magnesium), H2 receptor antagonists 
(e.g. ranitidine), and proton pump inhibitors (e.g. omeprazole). 
However, despite the large range of treatments gastric ulcer 
recurrence has long been thought to be an unavoidable feature 
of peptic ulcer disease, and therefore, maintenance treatment 
has been necessary to prevent recurrence (Arakawa et al., 2012).
During the past decade, complementary and alternative 
medicines have become a topic of global importance. Current 
estimates suggest that in many developing countries, a 
large portion of the population relies heavily on traditional 
practitioners and medicinal plants to meet primary healthcare 
needs. Although modern medicine may be available in these 
countries, herbal medicines (phytomedicines) have often 
maintained their popularity for historical and cultural reasons 
(Saraf and Saraf, 2012).
Carthamus tinctorius L. is a member of the family Asteraceae, it 
possibly originated in Southern Asia and is known to have been 
cultivated in China, India, Iran and Egypt almost from prehistoric 
times. During the middle ages it was grown in Italy, France, and 
Spain, and afterwards it was introduced into North and South 
America from the Mediterranean region (Bae et al., 2002). 
Carthamus tinctorius seeds are rich in edible oil (safflower 
oil), with similar content to olive, sunflower, and peanut oils 
(40% dry matter weight). This oil is composed of typically 
linoleic acid (63-72%), oleic acid (16-25%) and linolenic acid 
(1-6%) (Kim et al., 2000). 
The oral administration of safflower oil at doses of 750 mg/
kg in rodents has been proven to have thermogenic properties 
and may thus contribute to the treatment of obesity (Takeuchi 
et al., 1995). Other reports show that this oil has the capacity to 
relieve constipation and ease rheumatic pains, and that it has 
laxative and antifungal activities (Pintão and da Silva, 2008). 
However, despite the widespread use of safflower flowers for 
their pharmaceutical, cosmetic, and medicinal properties; 
there have been no studies regarding the use of this oil for the 
treatment of gastric ulcers, or tests to determine its rodent 
toxicity (side effects) and environmental risks of this oil.
Medicinal plant species that are being used to treat 
particular diseases on a large scale can have serious side 
effects (George, 2011). The likelihood of side effects increases 
when the production and sale of such products are largely 
uncontrolled and/or unregulated and the consumer is not 
adequately informed about their proper uses. Regulatory 
controls are therefore considered necessary to safeguard drug 
interactions with herbal drugs (WHO, 1997; 2002).
The monitoring of pharmaceutical compounds in 
environmental matrices has been addressed in several 
studies since the late 1990s. Drugs excreted by patients can 
contaminate rivers, even after treatment in wastewater-
processing facilities. In addition, there is mounting evidence 
that effluents from pharmaceutical factories could also be 
carrying drugs into the rivers (Gilbert, 2012). The effects are 
already evident: they include the feminization of fish by 
residues of contraceptive pills, and the death of millions of 
vultures on the Indian subcontinent following the ingestion of 
the anti-inflammatory drug diclofenac. Antibiotic overuse has 
led to the emergence of resistant pathogenic bacteria in the 
environment, and not just in medical settings (Deplege, 2011).
Given the need for new therapeutic approaches to treat 
gastric ulcer with a low probability of toxicological effects; 
added to concerns regarding the ecological risks of chemical 
compounds with therapeutic properties, this study aimed to 
evaluate the phytochemistry, antiulcer activity, and rodent 
and environmental toxicity of safflower oil. Our results will 
serve as the basis for new pharmacological assays involving 
the Safflower oil treatment for the gastric ulcer diseases.
Material and methods
Drugs and reagents
Carboxymethylcellulose (CMC), lansoprazole and safflower oil 
from Carthamus tinctorius L. Asteraceae, seed were purchased 
from Sigma-Aldrich, USA. Safflower oil (test substance) was 
used at doses of 93.75; 187.5; 375 and 750 mg/kg; whereas 
lansoprazole (positive control) was administered at a dose of 
30 mg/kg. Both substances were diluted in 0.5% CMC and the 
resulting solutions were administered at a concentration of 10 
ml/kg by the oral route (p.o.).
Analysis of safflower oil by dispersive Raman spectroscopy
Safflower oil has been evaluated using dispersive Raman 
spectroscopy. For that, a portable near-infrared, dispersive 
Raman system (Dimension P-1 Raman system, Lambda 
Solutions, Inc., MA, USA), with an 830 nm excitation, adjustable 
laser of 230 mW, and spectral resolution of about 2 cm-1 in 
the range of 400 to 1800 cm-1 was used. The spectrometer was 
connected to a Raman probe (Vector probe, Lambda Solutions, 
Inc. MA, USA) of about 3 m long, with band pass and rejection 
pass filters. The 1320×100 pixel, back-thinned, deep-depleted 
CCD detector was cooled down (Peltier) to -75°C to decrease 
thermal noise. For spectral collection, the safflower oil sample 
was placed in an aluminum sample holder with wells of 5 mm 
in diameter and 100 μl capacity; then the probe was placed at 
a 10 mm distance perpendicular to the sample surface (probe’s 
focal length). The sample spectra of oleic and linoleic acids 
(Sigma-Aldrich) were also obtained. The signal scattered by 
each sample was then collected by the probe and coupled to 
the signal port of the Raman spectrometer for dispersion and 
detection. The Raman signal was collected in 5 and 10 s scans 
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for all samples. Finally, the gross spectra were calibrated, 
pre-processed and stored for further analysis using Microsoft 
Excel software (Microsoft Office 2003). For calibration a Raman 
spectrum of naphthalene was measured and the known Raman 
shift of selected bands were compared with the respective 
Raman shifts found in the measurement. When needed, the 
x-axis was displaced to match the correct band shift. For 
pre-processing, cosmic rays spikes were manually removed 
and the background fluorescence was removed by fitting and 
subtracting a 5th order polynomial to the gross spectrum. No 
normalization was applied to the data.
Animals
We used male albino Swiss mice with an average weight of 
30-45 g. They were obtained from the Animal Facility of the 
Federal University of São Paulo. The animals were acclimated 
to the vivarium conditions of Santa Cecília University at a 
temperature of 23 ± 2ºC and a 12 h light-dark cycle. Mice had 
access to Nuvital and water ad libitum. The animals were kept 
in cages with raised floors of wide mesh to prevent coprophagy. 
All protocols employed were approved by the Unisanta 
Institutional Animal Care and Use Committee, following the 
recommendations of the Canadian Council on Animal Care 
(Olfert et al., 1993) under reference number 001/2012.
Hydrochloric acid (HCl)/ethanol-induced gastric ulcer
The methodology used was as previously described by Mizui 
and Doteuchi (1983). After a 12 h fasting the different groups 
of mice were treated orally with 0.5% CMC (10 ml/kg, p.o.) 
(negative control) (n = 5), lansoprazole 30 mg/kg (10 ml/kg, p.o.) 
(positive control) (n = 5), or safflower oil at a dose of 750 mg/
kg (10 ml/kg, p.o.) (n = 5). One hour after administration of the 
treatments, gastric damage was induced in animals by oral 
administration (0.1 ml/20 g body weight) of a solution of 150 mM 
HCl in 98% ethanol. After one hour the animals were sacrificed 
and the stomachs removed for s lesion counts, according to 
Szelenyi and Thiemer (1978). The number of gastric lesions 
after administration of HCl-ethanol was expressed as mean 
± standard deviation (SD). Statistical differences between 
experimental groups were detected by analysis of variance 
(ANOVA) followed by Dunnet’s test, with a significance level 
of p < 0.05 for all analyses. Statistical analyses were performed 
using the Graph Pad Prism Software 3.0®.
NSAID-Induced gastric ulcers in cholinomimetic-treated mice 
These experiments were performed in accordance with the 
method proposed by Rainsford (1978). In this model, a gastric 
ulcer was induced by indomethacin (30 mg/kg, s.c.) and 
bethanechol (5 mg/kg, i.p.) administration to mice after a 24 h 
fast. Safflower oil at four doses (93.75, 187.5, 375 and 750 mg/kg, 
p.o.), Lansoprazole (30 mg/kg, p.o.) or 0.5% CMC (10 ml/kg, p.o.) 
were administered orally 30 min before the induction of gastric 
ulcer. The animals were killed 4 h after treatment with the 
ulcerogenic agents; the stomachs were removed and inﬂated 
with 4% formalin in buffered saline, and the gastric damage 
was determined using the methodology of Szelenyi and 
Thiemer (1978). Statistical differences between experimental 
groups were determined by analysis of variance (ANOVA) 
followed by Dunnet’s and Tukey’s tests, with a significance 
level of p < 0.05 for all analyses.
Determination of gastric secretion
The assay was performed by the method of Shay (1945). All 
groups of mice fasted for 24 h, with free access to water. 
Immediately after pylorus ligature, safflower oil at a dose of 
187.5 mg/kg (10 ml/kg, p.o.) (n = 8); Lansoprazole 30 mg/kg (10 
ml/kg, p.o.) (n = 8) as positive control or 0.5% CMC (10 ml/kg, p.o.) 
(negative control) (n = 8) were administered intraduodenally. 
The animals were killed 4 h later; the abdomen was opened 
and another ligature was placed around the esophagus, close 
to the diaphragm. The stomachs were removed and the gastric 
content collected to determine the total amount of gastric acid 
(ml) and pH values. Distilled water (5 ml) was added, and the 
solution obtained was centrifuged at 2000× g for 10 min. Total 
acid in the gastric secretion was determined in the supernatant 
volume by titration to pH 7.0 with 0.01 N NaOH.
Determination of mucus in gastric content
This assay was performed following the methodology 
described previously by Sun et al. (1991). Mice fasted for 24 h, 
under anesthesia, the abdomen incised and the pylorus ligated. 
The safflower oil at a dose of 187.5 mg/kg (10 ml/kg, p.o.) (n = 8); 
Lansoprazole 30 mg/kg (10 ml/kg, p.o.) (n = 8) as positive control 
or 0.5% CMC (10 ml/kg, p.o.) (negative control) (n = 8) were 
administered intraduodenally (i.d.) after the pylorus ligature. 
The animals were killed 4 h after the drug treatments. The 
stomach content was immersed in 10 ml 0.02% alcian blue in 
0.16 M sucrose ‒ 0.05 M sodium acetate, pH 5.8, and incubated 
for 24 h at 20°C. The alcian blue binding extract was centrifuged 
at 2000× g for 10 min. The absorbance of the supernatant was 
measured at 615 nm using a light spectrophotometer U/2000 
(Hitachi, Japan). The free mucous in the gastric content was 
calculated from the amount of alcian blue binding (mg/wet 
tissue [g]).
Acute toxicity assay
For an acute toxicity test by single dose, the animals were 
divided into two groups with n = 10 for each group. The 
negative control group received 0.5% CMC (10 ml/kg, p.o.) and 
the test group received safflower oil at a dose of 5 g/kg, p.o. 
diluted in 0.5% CMC at a concentration of 10 ml/kg. Water 
and food consumption, the mass of waste products (feces and 
urine), and the body weight of the animals were assessed daily 
for seven days. At the end of the experimental protocol, the 
animals were sacrificed and their organs (heart, lung, liver and 
kidney) were macroscopically analysis (Brito, 1994).
Ecotoxicity assays with Daphnia simillis
This assay was performed according to US EPA (2002) guideline, 
with adaptations proposed by the Brazilian standardization 
protocol (ABNT, 2004). According to this protocol, neonates 
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Figure 1 – Raman spectra obtained from linoleic acid, oleic 
acid authentic standards and safflower analysis. The peaks 
observed at 1655 cm-1 and 1265 cm-1 are consistent with 
the presence of C=C alkyl stretching and C-H ethylene, 
respectively. The four peaks observed in the region of 800-
980 cm-1 exhibit a pattern consistent with the Raman spectra 
profile of linoleic acid (Baeten et al., 2001; Silveira et al., 2010; 
2012). Together, these observations indicate the presence 
of the unsaturated fatty acid linoleic acid, consistent with 
previously published data.
Figure 2 – Raman spectra obtained from the safflower oil 
analysis and a mixture of oleic and linoleic acid, suggesting 
that these two compounds are the main constituents 
of safflower oil in the concentrations shown in the plot. 
The arrows indicate the peaks at 1655 cm-1 and 1265 cm-1 
attributed to the unsaturated fatty acids. The Raman peaks 
marked with stars in the region between 800-1000 cm-1 
represent the characteristic peaks of linoleic acid.
According to Rudolphi et al. (2012), the seed oil of safflower 
(Carthamus tinctorius L., Asteraceae) has a high content of 
monounsaturated oleic and polyunsaturated linoleic acids, and 
is produced for nutritional as well as medicinal uses, due to its 
pharmacological properties. Linoleic acid is not synthesized by 
the human body and should therefore be consumed in the diet. 
In this study, the high concentrations of linoleic and oleic acids 
could be verified by the coincidence of the Raman peaks of these 
compounds found in the spectrum of safflower oil (Fig. 2).
Currently, there are several pharmacological options for the 
treatment of gastric ulcer disease. Some classes of therapeutic 
drugs include those that neutralize gastric acid (e.g. aluminum 
hydroxide and magnesium), H2 receptor antagonists (e.g. 
ranitidine, famotidine, nizatidine) and proton pump inhibitors 
(PPIs) (e.g. omeprazole, lansoprazole, pantoprazole). However, 
the use of acid-suppressing medications (H2 antagonists or 
proton pump inhibitors) was associated with an increased risk 
of hip fracture in a large, general population (Corley et al., 2010). 
In addition, Madanick (2011) reported that the US Food and 
Drug Administration has issued alerts mentioning that PPI may 
increase the rate of osteoporosis-related fractures, as well as 
decrease the effectiveness of clopidogrel for preventing serious 
cardiovascular events. Other concerns include increased rates 
of pneumonia, Clostridium difficile infection, and others. These 
data reinforce the need for ongoing studies that concern the 
development of new molecules that promote improvement in 
patients with gastric ulcer.
The classical model of gastric ulcer induced by the 
administration of an ethanol-HCl solution in mice is often 
used as the initial source for the study of probable substances 
with gastric mucosal protective properties. It is known 
that this experimental protocol is capable of reducing the 
cytoprotection of the gastric mucosa, particularly by reducing 
the concentration of prostaglandins (PGE2), which facilitates 
damage by hydrochloric acid, thereby promoting ulcerogenesis 
(Amandeep et al., 2012).
The results obtained following the administration of safflower 
oil (750 mg/kg, p.o.) in the ulcerogenic HCl-ethanol model showed 
a reduced ulcerogenic lesion index (ILU) (**p < 0.01) in comparison 
to the negative control group (0.5% CMC) (Fig. 3). 
of Daphnia similis were exposed to several concentrations of 
safflower oil diluted in 0.5% CMC for a period of 48 h. Four 
replicates for each concentration and controls were employed, 
with five organisms being added to each replicate, giving a 
total of twenty organisms per test concentration. In order to 
assess the possible effects of the solvent on the test organisms, 
the highest CMC concentration used for each experiment was 
simultaneously tested as the solvent control. At the end of 48 
h of exposure, immobility and mortality were analyzed and the 
maximal effective concentration (EC50) was calculated using 
the Trimmed Spearman-Karber statistical method.
Results and discussion
Dispersive Raman spectroscopy was employed for chemical 
composition analysis of safflower oil, as this analytical 
methodology allows a rapid and direct analysis without 
previous preparation of the samples, and with less waste 
generation when compared with conventional analytical 
techniques. The Raman spectra (Fig. 1) showed peak 
intensities at 1265 and 1655 cm-1 attributed to in-plane C-H 
ethylene deformation and C=C alkyl stretching, respectively, 
characteristic bands of unsaturated fatty acids, and a band with 
peak at 1300 cm-1  attributed to in-phase methylene twisting 
deformation vibration of fatty acids (Baeten et al., 2001). The 
band at 1442 cm-1 is attributed to C-H deformation of CH2 of 
lipids. The ratio of peaks at 1265 and 1301 cm-1 and at 1442 and 
1655 cm-1 also show a strong relationship with double bond 
content (Baeten et al., 2001; Silveira et al., 2010), which can 
be used to characterize the level of unsaturation of vegetable 
oils. Figure 2 shows a mixture of oleic and linoleic acids in 
a proportion that match the spectral features of these two 
compounds and the spectra of safflower oil (35% of oleic acid 
and 65% of linoleic acid). Moreover, the four peaks observed 
in the Raman spectral region of 800-1000 cm-1 clearly showed 
the presence of linoleic acid in the safflower oil.
542 Walber Toma et al. / Rev Bras Farmacogn 24(2014): 538-544
Treatments (i.d.) Dose (mg/kg) n pH (units) Volume gastric juice (ml) Total gastric acid (m Eq/4 h)
CMC 0.5 % 10 ml/kg 08 2.8 ± 0.4 1.44 ± 0.17 6.0 ± 0.6
Lansoprazole 30 08 4.8 ± 0.95*** 0.85 ± 0.18*** 1.5 ± 0.2***
Safflower oil 187.5 08 4.4 ± 1.2** 1.78 ± 0.26** 2.0 ± 0.25***
The results are expressed as mean ± SD. ANOVA for pH Units, Volume gastric juice and Total acid gastric with Dunnett’s test: **p < 0.01 and  
***p < 0.001 compared to the negative control group.
Table 1
Effects of safflower oil and lansoprazole administered intraduodenally (i.d.) on the biochemical parameters of gastric juice 
obtained from pylorus–ligature mice.
Figure 3 – The activity of antiulcerogenic safflower oil (750 mg/
kg) after oral administration in the model of gastric lesions 
induced by administration of HCl-ethanol in mice. Data are 
expressed as mean ± S.D. ANOVA followed by Dunnet´s test 
with *p < 0.01 and **p < 0.05.
Figure 4 – Effects of vehicle, safflower oil and lansoprazole 
on non-steroidal anti-inflammatory drug (NSAID) – 
induced gastric ulcers in cholinomimetic-treated mice. 
Data are expressed as mean ± S.D. ANOVA followed by 
Dunnett´s test. **p < 0.01; ***p < 0.001 compared to the 
0.5% CMC Control Group. The horizontal bars indicate 
comparisons between different pre-treatments (Safflower 
oil at dose of 187.5 mg/kg and 750 mg/kg), ANOVA followed 
by Tukey´s test with ns: no significant difference with 
p > 0.05.
The results of this experimental protocol served as an 
important evidence to establish  gastric ulcer induction of 
cholinomimetic-treated mice with anti-inflammatory drugs 
(NSAID)-treatment with four different doses (93.75, 187.5, 
375 and 750 mg/kg, p.o.) of safflower oil. In this protocol the 
safflower oil at doses of 187.5, 350 and 750 mg/kg demonstrated 
to significantly reduce damage to the gastric lesions when 
compared to the respective control. Statistical analyzes also 
show no significant differences between the doses of 750 
and 187.5 mg/kg (Fig. 4), a fact crucial to use the dose of 187.5 
following the pharmacological tests.
According to Stachowska et al. (2009), unsaturated fatty 
acids such as linoleic acid can be incorporated into cellular 
membranes in the form of phospholipids, free fatty acids 
or cholesterol esters. These are hydrolyzed by the enzyme 
phospholipase A2, which contributes to the synthesis of 
eicosanoids such as prostaglandins (PGE2). These PGE2 
in turn stimulate the secretion of mucus and mucosal 
bicarbonate, accelerate cell proliferation, enhance mucosal 
blood flow, and increase sulfhydryl groups in the mucosa, 
promoting lysosomal stability as well as the formation of 
mucosal phospholipids (Amandeep et al., 2012). All these 
cellular events mean that PGE2 are a large endogenous 
cytoprotective component of the gastric mucosa. We 
observed in the pylorus ligature protocols significant 
effects after administration of Safflower oil (187.5 mg/kg, 
i.d.), such as the increases of pH values (**p < 0.01), gastric 
juice volume (**p < 0.01) and reduction of total gastric acid 
(***p < 0.001), when compared to the negative control value 
group (Table 1). 
Moreover ,  the  saf f lower  o i l  (187 .5  mg/kg,  i .d . ) 
administration promotes the increase of mucous (***p < 
0.001) when compared to the negative control group (Fig. 
5). Since safflower contains large amounts of linoleic acid, 
it is therefore hypothesized that this is the cytoprotective 
mechanism involved in the pharmacological response 
observed in the pharmacological assays.
As important as the pharmacological evaluations 
are, it is also of great importance the evaluation of the 
toxicological properties of new compounds. Given the 
positive results obtained following the use of safflower 
oil in the experimental protocol to induce ulcerogenic 
lesions, an acute toxicity assay (single dose) was performed 
to determine the probable toxicological activity of the 
substance in question, thus providing information about 
the health risks resulting from short-term exposure through 
a chosen route. The acute toxicity assay may also provide 
initial information about the modes of action of a toxic 
substance (Brito, 1994). In this case, the oral administration 
of safflower oil at a dose of 5 g/kg (p.o.) did not have any 
effect on mortality, body weight, water consumption, 
feeding or excreta volume, when compared to the control 
group (CMC 0.5%).
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The presence of pharmaceuticals in the environment is 
now being reported worldwide. New data on the source, fate 
and effects of pharmaceuticals in the environment seem 
to indicate the possibility of a negative impact on different 
ecosystems, and also implies a threat to public health. As a 
result, data from acute and chronic toxicity tests on species 
belonging to different trophic levels such as bacteria, algae, 
crustaceans and fish, among others, are required in order 
to illustrate the adverse effects of environmental exposure 
to measured concentrations of these contaminants (Santos 
et al., 2010). Several drugs are detectable in aquatic systems 
at concentrations in the order of ng/l up to μg/l, and these 
values may vary under treatment practice, market basis and 
prevalence of disease (Isidori et al., 2009).
Taking into account the potential environmental risk of 
safflower oil discharges into aquatic environments, a toxicity 
assay was performed using the freshwater cladoceran Daphnia 
similis. The EC50 calculated by Trimmed Spearman Karber was 
223.17 mg/l (confidence limits 180.19 - 276.41) (Fig. 6). 
The European directive 93/67/EEC on risk assessment for 
new notified substances classifies the substances according 
to accurate results of toxicity (values of EC50, IC50), namely, 
substances with EC50 < 0.1 mg/l are classified as “extremely 
toxic”; between 0.1 and 1 mg/l are classified as “very toxic”; 
between 1 and 10 mg/l are classified as “toxic”; between 10 
and 100 mg/l are classified as “harmful”; and higher than 100 
mg.l-1 are considered to be “non-toxic” (CEC, 1996). Based on 
this directive, safflower oil can be classified as a “non-toxic” 
substance.
Antiulcerogenic compounds may have environmental 
toxicity. Ranitidine (an antiulcerogenic, antagonist of H2 
receptors) is in the top fifteen of prescribed drugs in various 
European countries (Fent et al., 2006), and the toxicological 
and eco-toxicological data of ranitidine and its photoproducts 
are known. Webb (2001), assessed the toxicity of ranitidine on 
Daphnia magna and reported an EC50 value for ranitidine of 650 
mg/l. Isidori et al. (2009) showed that ranitidine did not show 
any acute toxicity at the highest concentration tested (100 
mg/l) for B. calyciflorus and C. dubia. However, overall ranitidine 
toxicity could be linked to its photoproducts. In fact, the EC50 
of the two photoproducts for Brachionus calyciflorus were 0.248 
and 0.830 mg/l, while for Ceriodaphnia dubia, the EC50 values 
were 0.007 and 0.510 mg/l (Isidori et al., 2009). 
Based on the data reported herein, we can conclude 
that safflower oil shows significant antiulcer activity 
when administered at a dose of 187.5 mg/kg orally and 
intraduodenally. Its antiulcerogenic activity may be attributed 
to the presence of linoleic acid, and the probable mechanism 
might involve its cytoprotective activity in the gastric mucosa. 
Likewise, safflower oil at a dose of 5 g/kg had no toxic effects 
on rodent models and according EC50 obtained from Daphinia 
similis protocols The European directive 93/67/EEC classified 
the safflower oil as “non-toxic” substance. We conclude that 
this study provided important data regarding the biochemical, 
pharmacological, toxicological and environmental effects of 
safflower oil.
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Figure 5 – Effects of vehicle, safflower oil and carbenoxolone on 
adherent gastric mucous after pylorus ligature in rats. Data are 
expressed as mean ± S.D. ANOVA followed by Dunnett´s test. 
***p < 0.001 compared to the 0.5% CMC Control Group.
Figure 6 – Results of acute ecotoxicity assay on Daphnia 
similis (means and standard deviation). At the end of 48 h of 
exposure, immobility and mortality were analyzed and the 
maximal effective concentration (EC50) was calculated using 
the Trimmed Spearman Karber statistical method.
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